May 30, 2025
Successful Marketing Transformation Step Boosts PEHA Sales by 79% in Q1/2025 for Over-the-Counter (OTC) Medications
Phapros' successfully recorded a 79% year-on-year (YoY) sales growth in the over-the-counter (OTC) segment...
See More
May 26, 2025
Targeting Sales Growth in 2025, Phapros (PEHA) Strengthens Marketing Through These 3 Strategies
Phapros' focuses on implementing 5 key strategies in its business and financial transformation....
See More
March 20, 2025
PT Phapros Tbk Launches Category 1 Daily Dose OAT Package to Support TB Treatment in Indonesia
Phapros' officially launched the Category 1 Daily Dose OAT Package, an antituberculosis medication in the form of coated tablets. ...
See More
February 24, 2025
Achieving PROPER Green, PT Phapros Tbk Committed to Preserving the Environment
PT Phapros Tbk once again received the 9th PROPER Green award at the 2025 PROPER Awards ...
See More
December 20, 2024
Ahead of the Nataru Holiday Season, Phapros Increases Antimo Production by 43 Percent, Targeting 9 Percent Growth
In anticipation of the 2024 Christmas and 2025 New Year (Nataru) holiday season, Phapros, through Antimo Group, is organizing a series of activities to support the comfort of travelers....
See More
October 30, 2024
Phapros' Export Performance Rises Nearly 200% in the Third Quarter of 2024
Phapros continues to aggressively expand as part of its strategy to increase revenue by the end of this year. ...
See More